Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunogenicity of a bivalent virus-like particle norovirus vaccine in children from 1 to 8 years of age: A phase 2 randomized, double-blind study
Timo Vesikari, Xavier Sáez‐Llorens, Vesna Blazevic, et al.
Vaccine (2022) Vol. 40, Iss. 26, pp. 3588-3596
Open Access | Times Cited: 20

Showing 20 citing articles:

Norovirus replication, host interactions and vaccine advances
B. V. Venkataram Prasad, Robert L. Atmar, Sasirekha Ramani, et al.
Nature Reviews Microbiology (2025)
Closed Access | Times Cited: 1
Viral gastroenteritis
Thomas G. Flynn, Maribel Paredes Olórtegui, Margaret Kosek
The Lancet (2024) Vol. 403, Iss. 10429, pp. 862-876
Closed Access | Times Cited: 14
Mucosal and systemic neutralizing antibodies to norovirus induced in infant mice orally inoculated with recombinant rotaviruses
Takahiro Kawagishi, Liliana Sánchez-Tacuba, Ningguo Feng, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 9
Open Access | Times Cited: 20
Strategic and scientific contributions of human challenge trials for vaccine development: facts versus fantasy
Yara‐Natalie Abo, Euzebiusz Jamrozik, James McCarthy, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 12, pp. e533-e546
Open Access | Times Cited: 17
Safety and immunogenicity of a bivalent norovirus vaccine candidate in infants from 6 weeks to 5 months of age: A phase 2, randomized, double-blind trial
Xavier Sáez‐Llorens, Rodrigo DeAntonio, Eduardo López-Medina, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
Proteomics as a Complementary Approach to Measure Norovirus Infection in Clinical Samples
Jonathan P. Davies, Alejandra Ingunza, Bia Peña, et al.
Virology (2025), pp. 110502-110502
Closed Access
Immunogenicity and tolerability of a bivalent virus-like particle norovirus vaccine candidate in children from 6 months up to 4 years of age: A phase 2 randomized, double-blind trial
Pío López, Eduardo López-Medina, Xavier Sáez‐Llorens, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 12
A randomized, double-blind, placebo-controlled, dose-escalating phase I trial to evaluate safety and immunogenicity of a plant-produced, bivalent, recombinant norovirus-like particle vaccine
Isabel Leroux‐Roels, Cathy Maes, Jasper Joye, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 15
Lactobacilli as a Vector for Delivery of Nanobodies against Norovirus Infection
Yoshikazu Yuki, Fanglei Zuo, Shiho Kurokawa, et al.
Pharmaceutics (2022) Vol. 15, Iss. 1, pp. 63-63
Open Access | Times Cited: 15
Unraveling the interplay between norovirus infection, gut microbiota, and novel antiviral approaches: a comprehensive review
Geng-Hao Bai, Meng-Chen Tsai, Sheng‐Chieh Lin, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 4
Attitudes toward a future norovirus vaccine among members of an integrated healthcare delivery system in Portland, Oregon, 2016-2017
Holly C. Groom, Mark A. Schmidt, Laura E. Calderwood, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Immune responses in healthy adults elicited by a bivalent norovirus vaccine candidate composed of GI.4 and GII.4 VLPs without adjuvant
Gwenn Waerlop, Yorick Janssens, Bart Jacobs, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Development and characterization of a plant-derived norovirus-like particle vaccine
Janna R. Shapiro, Guadalupe Andreani, Charlotte Dubé, et al.
Vaccine (2023) Vol. 41, Iss. 41, pp. 6008-6016
Closed Access | Times Cited: 4
High prevalence of norovirus GII.4 Sydney among children with acute gastroenteritis in Bangladesh, 2018–2021
Nadim Sharif, Shamsun Nahar Ahmed, Nazmul Sharif, et al.
Journal of Infection and Public Health (2023) Vol. 16, Iss. 7, pp. 1015-1022
Open Access | Times Cited: 2
Biological and physico-chemical characterization of human norovirus-like particles under various environmental conditions
Nicole Abou-Hamad, Marie Estienney, Rémi Chassagnon, et al.
Colloids and Surfaces B Biointerfaces (2023) Vol. 231, pp. 113545-113545
Closed Access | Times Cited: 2
Gastroenterite pediátrica ocasionada pelo norovírus
Amanda Lobato Potiguar Abrahão, Ananda Carolina Reis Prestes, Leonardo Rodrigues Ferreira Diogo, et al.
Revista Eletrônica Acervo Saúde (2024) Vol. 24, Iss. 7, pp. e16132-e16132
Open Access
Production of Norovirus VLPs of the Nine Representative Genotypes Widely Distributed in Japan using the Silkworm-Baculovirus Expression Vector System
Yuto Tsurumi, Keisuke Morimoto, Akitsu Masuda, et al.
Journal of Virological Methods (2024) Vol. 331, pp. 115038-115038
Open Access
An effectively protective VLP vaccine candidate for both genotypes of feline calicivirus
Yupeng Yang, Zhe Liu, Mengru Chen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Mucosal and systemic neutralizing antibodies to norovirus and rotavirus by oral immunization with recombinant rotavirus in infant mice
Takahiro Kawagishi, Liliana Sánchez-Tacuba, Ningguo Feng, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Closed Access | Times Cited: 2
Epidemiology of Norovirus in the First 2 Years of Life in an Australian Community-based Birth Cohort
Asmaa El‐Heneidy, Keith Grimwood, Gabor Mihala, et al.
The Pediatric Infectious Disease Journal (2022) Vol. 41, Iss. 11, pp. 878-884
Closed Access | Times Cited: 1
Page 1

Scroll to top